LABTVSNIVF• 3 Months (Normalized)
LABT vs NIVF (Lakewood-Amedex Biotherapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $1.78
-48.85%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-87.37%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
+38.52 pts
LABT outperforming by 38.52 percentage points
LABTNIVF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | LABT Price | LABT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.78 | -48.85% | $0.59 | -87.37% | +38.52% |
| Sep 22, 2026 | $1.99 | -42.82% | $0.73 | -84.29% | +41.47% |
| Sep 21, 2026 | $2.05 | -41.09% | $0.72 | -84.59% | +43.50% |
| Sep 18, 2026 | $1.99 | -42.82% | $0.72 | -84.61% | +41.79% |
| Sep 17, 2026 | $1.86 | -46.55% | $0.72 | -84.69% | +38.14% |
| Sep 16, 2026 | $2.09 | -39.94% | $0.79 | -83.19% | +43.25% |
| Sep 15, 2026 | $2.17 | -37.64% | $0.84 | -82.02% | +44.38% |
| Sep 14, 2026 | $2.12 | -39.08% | $0.93 | -80.11% | +41.03% |
| Sep 11, 2026 | $2.22 | -36.21% | $1.06 | -77.31% | +41.10% |
| Sep 10, 2026 | $2.05 | -41.09% | $1.11 | -76.24% | +35.15% |
| Sep 09, 2026 | $2.32 | -33.33% | $1.10 | -76.45% | +43.12% |
| Sep 08, 2026 | $2.18 | -37.36% | $1.11 | -76.24% | +38.88% |
| Sep 04, 2026 | $1.88 | -45.98% | $1.14 | -75.59% | +29.61% |
| Sep 03, 2026 | $1.90 | -45.40% | $1.18 | -74.74% | +29.34% |
| Sep 02, 2026 | $2.07 | -40.52% | $1.21 | -74.10% | +33.58% |
Page 1 of 5